The MMLP device, introduced here for the first time, is presented as an auspicious approach for reanimating the eyelid in bidirectional eyelid paralysis, achieving a fully automated and complete opening and closure during the blink. To our knowledge, this is the first proof of concept in a living patient for any prosthetic technology to address bidirectional paralysis in or around the eye and face. Prior work with magnetic actuators for unidirectional severe blepharoptosis has already demonstrated, via open-label
19,20,25 and a randomized clinical trial,
21 high fitting success rates in more than 50 participants with severe ptosis with very few adverse events in the short term
29 or longer term.
22 Hence, it was expected that the MMLP would achieve similar success in opening the eye in bidirectional paralysis, as demonstrated in this specific case. The results by FEA predicted that the necessary forces could be achieved with a 12.7 × 12.7 N52 diametric frame magnet and a magnetic array with array magnets, which was subsequently confirmed in vivo. The response observed in this pioneering case was excellent, with the expected full eyelid elevation in the opening phase as well as rapid and complete fully automated blinking during the closing phase. The response was consistent over several cycles during the ∼1 minute trial. Video analysis of eyelid motion hints that the MMLP generates a blink speed that approximates the speed of a volitional blink and approaches the spontaneous blink velocity.
30
The size of the system was considered clinically feasible, based on the clinician author (K.E.H.) and participant feedback and was supported by the participant's strong interest in wearing the device for an extended trial after experiencing its impact on their eyelid function. Additionally, the comfort level was found to be acceptable by the participant during this brief trial. A larger human subject study with longer wear times is appropriate at this stage. As this patient also has a cranial nerve V palsy, the sensation on their eye, orbit, and face may be diminished, and this limited sensation may have contributed to the tolerability of the device. It must be noted that, with our experience with the traditional MLP, discomfort does not arise from the cornea but is related to pulling sensations on the eyelids. The motor noise is not too high but it might not be possible to neglect this level of noise when used for a long time. The noise is attributed to the gear train attached to the motor. Redesigning the system to avoid the need for a gear train will significantly reduce the noise.
Safety concerns that could result from the magnetic interaction of the device with other common items such as electronics, magnetic resonance imaging, orbital and facial reconstruction hardware, or implantable cardioverter–defibrillators (ICDs) have been considered and are being monitored for issues in prior and ongoing chronic use studies. The safety concern is bidirectional; that is, the safety concern can arise from an external magnetic field that is applied on the device or the magnetic field from the device acting on other components. For the former case, the concerns are minimal because of a variety of factors. First, the device is fully external so in case of emergency the device can be easily removed. Second, the biggest interaction with any external field will be that by the frame magnet, as it is the strongest magnetic element. The frame is not attached and will fall off the user if it interacts with an external field. The array magnets, though attached with Tegaderm tape, are enclosed in a PDMS packing. In our experience, this PDMS packing is easy to break, and array magnets under the external field will break out of this packaging before causing any serious injury to the skin due to a pulling action. The users should be informed of this concern and should be advised to refrain from using the device in regions of a high magnetic field such as magnetic resonance imaging rooms and near large magnets. The functionality of MLPs is susceptible to other magnetic fields but such effects can safely be assumed to be minimal because the region of operation of array magnets is greatly dominated by the field from the frame magnet on account of its proximity and strength.
A second type of magnetic interaction must also be discussed—the influence on other devices due to the magnetic field from the device. Modern orbitofacial reconstruction implants are mostly made of titanium, which is paramagnetic. Electrical implants such as ICDs can theoretically be affected by small neodymium magnets,
31,32 but there are no reported cases in the clinical literature. Users with ICDs are advised to prevent MLP contact with the chest and regions adjoining the ICD site as a precautionary measure. Many recent ICDs are rated MRI-safe. Such ICDs are practically immune to interaction with any external magnetic field.
It was discovered in this experiment that the flange thickness (the bonded section between the PDMS cube containing the three cube magnets that connect it to the skin adhesive outside surface) may be an important parameter for device functioning. During frame magnet rotation, the array has the propensity to roll in addition to the expected primary translational movement.
25 The moment of inertia of the array seemed to be increased by an expanded flange area and thickness, thereby improving its resistance to rotation. Furthermore, a wider flange can function as a physical barrier against rotation due to the limited available space. Further studies might also examine torque on magnetic array in addition to force.
Although bidirectional eyelid paralysis is rare, it has dire consequences and deserves the attention of the ophthalmic community. Research on this condition faces challenges in recruitment due to its rarity and the absence of a unique International Classification of Diseases, 10th Revision (ICD-10) code. The establishment of a registry is a potential solution. It could provide an avenue for recruitment, capture data on prevalence and quality-of-life impacts, and provide a platform for education, support, and public awareness.
The MMLP approach offers several advantages over the extension of other methods,
6–17 including solenoid, mechanical, soft ptosis crutch/speculum robot, or electromagnet approaches. First, MMLP allows for complete non-invasive testing, bypassing the need for animal studies and enabling direct testing in humans. In contrast, the proposed solenoid tether system has not been suggested as an externally fixed device. It would be challenging to prevent the tethers from slipping under hydrocolloid adhesive, even with surgical implantation, and the lateral force generated by the tether, although somewhat comparable to forces generated by the orbicularis, differs significantly from the upward and posterior force generated by the levator. This may result in an unnatural appearance and repeated mechanical pressure on the corneal apex, which can be problematic for patients with fragile corneas. Although the MMLP also exerts some mechanical pressure on the corneal apex, it does so to a much lesser extent, as no lateral tension is involved. In the case of the soft crutch system,
33 it is likely to share similar drawbacks, including the risk of repeated mechanical pressure and cosmetic unacceptability, as the prototype appears bulky in photographs. Notably, our participant expressed enthusiasm at the prospect of having a system to take home for a more extended trial. A more optimized design will be developed in the future to address these issues.
The optimization of the level of control granted to the subject is deemed crucial. Although providing the subject with some control over the device is advantageous, there should be limits on how much the calibration can be adjusted for safety reasons. The subjects can be allowed to activate and deactivate the device to synchronize blink initiation manually or to control the frequency of blinking within limits. During the design stage, the blink cycle and rate duration should be precalibrated, and blink synchronization should be accomplished through subject training before utilizing the frame.
The feasibility of delivering sufficient forces through the designed system has been demonstrated. Due to the unique capabilities of this device, it is anticipated to exert a significant impact and prove highly beneficial to patients afflicted by such a condition. The theoretical analysis conducted using FEA closely aligns with the measured requirements, indicating a sufficiently intricate analysis. This alignment is further reinforced by the satisfactory performance of the device during the trial. Therefore, it is believed by the authors that this analysis is adequate for establishing the proof of concept. The device will be tested on multiple subjects to quantify its performance and capabilities in future endeavors.